Nidda Healthcare GmbH

  • Land: Deutschland

Nachricht vom 13.11.2018 | 09:41

Nidda Healthcare GmbH: Bain Capital and Cinven announce final result of their Public Delisting Tender Offer for the remaining STADA shares

DGAP-News: Nidda Healthcare GmbH / Key word(s): Offer/Delisting

13.11.2018 / 09:41
The issuer is solely responsible for the content of this announcement.


 

  • Approximately 28.29 percent of the share capital and the voting rights of STADA tendered during acceptance period
  • Following settlement of the delisting tender offer Nidda Healthcare GmbH will hold approximately 93.61 percent of the share capital and voting rights of STADA
  • STADA management board has applied for delisting of STADA shares

Frankfurt / Munich, 13 November 2018 - Nidda Healthcare GmbH (the "Bidder" or "Nidda Healthcare"), a holding company controlled by funds advised by Bain Capital Private Equity (Europe), LLP and Cinven Partners LLP, last night published the final result of its public delisting tender offer ("Offer") for all shares of STADA Arzneimittel AG ("STADA" or the "Company") not already directly held by the Bidder. Approximately 28.29 percent of the share capital and the voting rights of STADA not already directly held by the Bidder were tendered during the acceptance period, which ended on 8 November 2018. Together with the shares already owned by the Bidder and following settlement of the Offer, which will occur at the latest on 28 November 2018, the Bidder will hold approximately 93.61 percent of the share capital and voting rights of STADA. The Offer was unconditional and there will be no additional acceptance period.

Meanwhile, STADA has filed all necessary applications for the revocation of the listing of the STADA shares.

The offer document and all other information about the Offer are available on the following website: www.niddahealthcare-offer.com


Media contacts:

 
For Bain Capital
Hazel Stevenson                                           
T   +44 (0) 20 375 74 989                                 
M  +44 (0) 798 600 97 20                          
E   hazel.stevenson@camarco.co.uk        
 
Ed Gascoigne-Pees
T   +44 (0) 20 375 74 984
M +44 (0) 788 400 19 49
E   ed.gascoigne-pees@camarco.co.uk
 
 
For Cinven
Vanessa Maydon                                          
T   +44 (0) 20 766 13325                            
M +44 (0) 7802 961 902                             
E   vanessa.maydon@cinven.com
 
Lutz Golsch
T   +49 69 92037 110                                  
M +49 173 651 7710
E   lutz.golsch@fticonsulting.com
 
 

About Bain Capital Private Equity:

Bain Capital Private Equity has partnered closely with management teams to provide the strategic resources that build great companies and help them thrive since its founding in 1984. Bain Capital Private Equity's global team of approximately 240 investment professionals creates value for its portfolio companies through its global platform and depth of expertise in key vertical industries including healthcare, consumer, financial and business services, industrials, and technology. Bain Capital's broader platform has offices in Boston, Chicago, New York, Palo Alto, San Francisco, Dublin, London, Luxembourg, Madrid, Munich, Melbourne, Mumbai, Hong Kong, Shanghai, Guangzhou, Seoul, Sydney and Tokyo and has made investments in more than 320 companies to date. In addition to private equity, Bain Capital invests across asset classes including credit, public equity, venture capital and real estate managing approximately USD 105 billion in total and leveraging the firm's shared platform to capture opportunities in strategic areas of focus.

For more information, visit www.baincapitalprivateequity.com

 

About Cinven:

Cinven is a leading international private equity firm focused on building world-class European and global companies. Its funds invest in six key sectors: Healthcare, Business Services, Consumer, Financial Services, Industrials, and Technology, Media and Telecommunications (TMT). Cinven has offices in key locations including: Frankfurt, London, Paris, Milan, Madrid, Hong Kong, and New York. Since 1988, Cinven funds have invested in 120 companies worth around EUR90 billion. Today Cinven has more than EUR15 billion in assets under management. Cinven takes a responsible approach towards its portfolio companies, their employees, suppliers, local communities, the environment and society.

For more information, please visit www.cinven.com

Important Notice

This announcement is neither an offer to purchase nor a solicitation of an offer to sell shares of STADA. The definite terms of the Offer, as well as further provisions concerning the Offer, are published in the offer document. Investors and holders of STADA shares are strongly advised to read the offer document and all other relevant documents regarding the Offer, since they contain important information.

The Offer was issued exclusively under the laws of the Federal Republic of Germany and certain applicable provisions of U.S. securities law. Any contract that is concluded on the basis of the Offer will be exclusively governed by the laws of the Federal Republic of Germany and is to be interpreted in accordance with such laws.



13.11.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


show this

Events im Fokus

Termine 2022

1./2. Juni 2022: Fachkonferenz Immobilien & Software | IT

13./14. Juli 2022: Fachkonferenz Beteiligungsgesellschaften & Consumer/Leisure

12./13. Oktober 2022: Fachkonferenz Finanzdienstleistungen/Technologie

Aktueller Webcast

Kinarus Therapeutics Holding AG

Replay KOL Webcast: Christian Pruente on wAMD and KIN001

27. Juni 2022

Aktuelle Research-Studie

FORTEC Elektronik Aktiengesellschaft

Original-Research: FORTEC Elektronik AG (von Montega AG): Kaufen

01. Juli 2022